Logo image
Dr. Roberto Chiarle working place, European Institute of Oncology Milan
Dr. Roberto Chiarle
Excellent
AiroScore
9.70

Dr. Roberto Chiarle

hematological pathology
hematological pathology
User ScoreExperienceRatingPrice RangePublicationsOnline Consultations
91%27 years9.7/10$$$$203No

Overview

Country, City
Italy, Milan
Health facility
European Institute of Oncology Milan
Medical unit
Department of hemolymphopathological diagnosis

About the doctor

Dr. Roberto Chiarle is a highly experienced hematological pathologist with 26 years of experience. He obtained his medical license after studying human medicine at the University of Torino and completing his residency in pathology at the same university. Dr. Chiarle further specialized in hematological pathology and conducted research at prestigious institutions like the New York University Medical Center and Harvard University. Dr. Chiarle currently works at the European Institute of Oncology in Milan, where he is the Director of the Department of Hemolymphopathological Diagnosis. His extensive expertise in the field is evident from his 203 scientific publications, which cover a wide range of topics including lymphoma, thymoma, and genetic mutations. His research has been recognized with grants from the European Research Council, National Institutes of Health, and several other foundations. With his vast knowledge and experience, Dr. Chiarle is considered an authority in his field. His contributions to the understanding and treatment of hematological disorders have been invaluable. Patients at the European Institute of Oncology can benefit from his expertise and innovative approaches to diagnosis and treatment. Dr. Roberto Chiarle is an exceptional doctor who combines extensive academic achievements with practical experience, making him a valuable asset to his profession.

Skills & Expertise

lymphoma
cancer
anaplastic
anaplastic lymphoma
large cell lymphoma
tumor
carcinoma
immunoglobulin
bcl6
bcl2
bcell
crisprcas9
oncogene
p53
fbxo11
mutations
mantlecell lymphoma
burkitt lymphoma
tcell
leukemia
lymphoproliferative disorders
follicular lymphoma
b cell lymphoma
lymphocytes
antipd1 therapy
alkrearranged lymphoma
cd40 regulation
lymphoid infiltrates
abnormal myelopoiesis
erbb2 oncogene
malignant tcell
lymphoid cancers
leukocyte transmigration
neoplastic cells
cdc42 activation
proapoptotic gene
antiangiogenic therapy
megakaryoblastic leukemia
myeloid cell
congenital anemia
combined immunodeficiency
mantle cell
lymphoblastic lymphoma
hematological disorders
lymphocytic leukemia
lymphocytic lymphoma
nonhodgkins lymphoma
multiple myeloma
leukocyte
anemia

Resume

CV (Curriculum Vitae)

Education
  • Studied human medicine at the University of Torino
  • Obtaining a license for medical practice
  • 1997 Completed residency in pathology at the University of Torino
  • 2001 Fellow and Researcher at the Department of pathology of the New York University Medical Center
  • Obtaining specialization in hematological pathology
  • 2008-2010 Visitor Professor at the Dr. Fred Alt laboratory of the Institute Harvard University in Boston
  • 2014 Received a medical license from the Massachusetts board of medicine
Experience
  • 2012 Department of pathology at the Boston Children's Hospital of the Harvard Medical School
  • 2012 Associate Professor of pathology at the Harvard Medical School
  • 2014 Full Professor of pathology at the University of Torino
  • Director of the Department of hemolymphopathological diagnosis at the European Institute of Oncology Milan
Awards & Memberships
  • Research Principal Investigator in pathology at the Boston Children's Hospital
  • International Prize from the Italian Academy of Sciences
  • European Research Council grants
  • The grant from the Association for International Cancer Research
  • Grants from the National Institutes of Health
  • Grants from the LUNGevity Foundation and Ellison Foundation

Languages

English flag
English
Italian flag
Italian

Publications

SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment.

1 November, 2023

Exploiting signaling rewiring in cancer cells with co-existing oncogenic drivers.

November, 2023

Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia.

October, 2023

Location

Via Giuseppe Ripamonti, 435, 20141 Milan, Italy

FAQ

Where does the doctor practice?

What is the specialization of Dr. Roberto Chiarle?

The primary specialization of the doctor is hematological pathology.

What is the experience of the specialist?

Dr. Roberto Chiarle has been practicing for more than 27 years.

What is the rating of the doctor?

Dr. Roberto Chiarle is rated as 9.70 by AiroMedical.

What topics does Dr. Roberto Chiarle expert at?

The doctor has excellent knowledge in lymphoma, cancer, anaplastic, anaplastic lymphoma, large cell lymphoma.

Is the specialist involved in the research?

Does the specialist offer online consultations?

No, Dr. Roberto Chiarle doesn’t perform virtual appointments.

Dr. Roberto Chiarle
Dr. Roberto Chiarle

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Dr. Roberto Chiarle

Similar Doctors

Dr. Rocco Pastano
Excellent
AiroScore
9.70
European Institute of Oncology Milan
hematology, stem cell transplantation, oncology
Dr. Alberto Agazzi
Excellent
AiroScore
9.70
European Institute of Oncology Milan
stem cells, apheresis, and hematology
Dr. Enrico Derenzini
Excellent
AiroScore
9.70
Dr. Francesco Bertolini
Excellent
AiroScore
9.70
Prof. Dr. Stefano Cascinu
Excellent
AiroScore
9.60
Prof. Dr. Alessandro Aiuti
Excellent
AiroScore
9.60
Dr. Marinone Carlo
Excellent
AiroScore
9.20
Saint Caterina da Siena Clinic Turin
internal medicine, hematology, and medical oncology
Prof. Dr. med. Lars Bullinger
Excellent
AiroScore
10.00
University Hospital Charite Berlin
haematology, oncology, leukaemia research, tumor immunology
Prof. Dr. med. Ulrich Keilholz
Excellent
AiroScore
10.00
University Hospital Charite Berlin
oncology, haematology, biological therapy of cancer